Skip to main content

Table 4 Nadir PSA subgroups and their corresponding 5 and 10-years biochemical free survival

From: Nadir PSA is a strong predictor of treatment outcome in intermediate and high risk localized prostate cancer patients treated by definitive external beam radiotherapy and androgen deprivation

Subcategories 5-years BFS rate (%) 10-years BFS rate (%)
nPSA < 0.06 95.7 79.6
0.06 < nPSA < 0.5 76.6 58.8
nPSA > 0.5 56 0